Compare COR & NDAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COR | NDAQ |
|---|---|---|
| Founded | 2001 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4B | 49.7B |
| IPO Year | N/A | 2002 |
| Metric | COR | NDAQ |
|---|---|---|
| Price | $339.01 | $90.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $351.08 | $101.71 |
| AVG Volume (30 Days) | 1.6M | ★ 2.6M |
| Earning Date | 11-05-2025 | 10-21-2025 |
| Dividend Yield | 0.71% | ★ 1.20% |
| EPS Growth | 5.71 | ★ 66.50 |
| EPS | ★ 7.96 | 2.80 |
| Revenue | ★ $321,332,819,000.00 | $8,168,000,000.00 |
| Revenue This Year | $7.04 | N/A |
| Revenue Next Year | $6.48 | $7.75 |
| P/E Ratio | $42.67 | ★ $32.22 |
| Revenue Growth | 9.31 | ★ 16.40 |
| 52 Week Low | $223.92 | $64.84 |
| 52 Week High | $377.54 | $97.63 |
| Indicator | COR | NDAQ |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 58.50 |
| Support Level | $333.39 | $87.79 |
| Resistance Level | $377.54 | $91.26 |
| Average True Range (ATR) | 7.65 | 1.52 |
| MACD | -5.20 | 0.31 |
| Stochastic Oscillator | 12.73 | 83.85 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.